Masimo, a Danaher company, has received FDA 510(k) clearance for an opioid-induced respiratory depression (OIRD) detection capability integrated into its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE